Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weiner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Pharmacology, Biochemistry, and Behavior|June 7, 2008
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey modelKimberly E Vanover, Adrienne J Betz, Suzanne M Weber, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Nature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
European Journal of Pharmacology|June 21, 2008
The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferationJakob Lerche Hansen, Mark Aplin, Jonas Tind Hansen, et al.
Urology|January 25, 2019
The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic HematuriaAshley N Gonzalez, Michael J Lipsky, Gen Li, et al.
The Journal of Biological Chemistry|November 20, 2008
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?Jakob L Hansen, Jonas T Hansen, Tobias Speerschneider, et al.
Current Pharmaceutical Design|May 23, 2006
Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readoutEthan S Burstein, Fabrice Piu, Jian-Nong Ma, et al.
Journal of Parkinson'S Disease|November 8, 2018
A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinKalpana M Merchant, Jesse M Cedarbaum, Patrik Brundin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonistKimberly E Vanover, Scott C Harvey, Thomas Son, et al.
Urology Practice|June 24, 2024
Multidisciplinary Development and Implementation of a Trial of Void Algorithm to Standardize and Reduce Indwelling Urethral Catheter UseDavid S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|June 7, 2008
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey modelKimberly E Vanover, Adrienne J Betz, Suzanne M Weber, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Nature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
European Journal of Pharmacology|June 21, 2008
The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferationJakob Lerche Hansen, Mark Aplin, Jonas Tind Hansen, et al.
Urology|January 25, 2019
The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic HematuriaAshley N Gonzalez, Michael J Lipsky, Gen Li, et al.
The Journal of Biological Chemistry|November 20, 2008
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?Jakob L Hansen, Jonas T Hansen, Tobias Speerschneider, et al.
Current Pharmaceutical Design|May 23, 2006
Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readoutEthan S Burstein, Fabrice Piu, Jian-Nong Ma, et al.
Journal of Parkinson'S Disease|November 8, 2018
A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinKalpana M Merchant, Jesse M Cedarbaum, Patrik Brundin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonistKimberly E Vanover, Scott C Harvey, Thomas Son, et al.
Urology Practice|June 24, 2024
Multidisciplinary Development and Implementation of a Trial of Void Algorithm to Standardize and Reduce Indwelling Urethral Catheter UseDavid S Han, Srinath-Reddi Pingle, Lovie M Amolo, et al.
Pageof 4